Skip to main content
. 2019 May 11;11(5):229. doi: 10.3390/pharmaceutics11050229

Figure 6.

Figure 6

Serum norovirus (NoV)-specific antibody responses induced by equal doses of NoV VLPs and rotavirus (RV) VP6. Groups of mice immunized either with 1 µg of NoV GI.4 and GII.4-2006a VLPs or combined with 1 µg VP6 were individually tested for (A) GI.4- and (B) GII.4-2006a-specific serum IgG with two-fold dilutions starting at 1:200. Control (Ctrl) mice received carrier only. Pooled serum of both groups was tested for blocking of VLP binding using pig gastric mucin (PGM)–based assay. Shown are blocking titration curves of (C) GI.4 and (D) GII.4-2006a VLP binding. Horizontal dashed line represents 50% blocking.